MedTrace Logo

Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells

NCT01803347 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-04-19

No results posted yet for this study

Summary

Efficacy of treatment of perianal fistula with mesenchymal stem cells and surgery

Conditions

  • Anal Fistula

Interventions

DRUG

◦Drug: ASCs. + fibrin glue

Experimental group

DRUG

fibrin glue

•Active Comparator: Fibrin glue Intervention: Drug: Fibrin adhesive

Sponsors & Collaborators

  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

    lead OTHER

Principal Investigators

  • Damián García-Olmo, Prof. · Instituto de Investigación Hospital Universitario La Paz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01803347 on ClinicalTrials.gov